ALB and Hypoalbuminemia: Although hypoalbuminemia was more common in this report than in the POLARIX study, the median albumin level in this study was 3.2 g/dL (2.1–4.5) vs 3.7 g/dL (1.7–5.4) in the POLARIX trial.